Furthermore, ALK-rearranged NSCLC present with fewer non-synonymous mutations compared with smoking associated NSCLC [55], that result in a less inflamed TME as well as less neo-antigen generation, leading to a potentially weaker response to ICI. Here, ALK is linked to non-small cell lung carcinoma.